Previous Investigations
Other Litigations Vioxx Research Center News & Warnings
|
Who's Who in Vioxx Safety - The FDA's List of Committee Participants
Your Vioxx lawyer provides you the complete transcript of the February 16th, 2005 joint meeting of the FDA's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. We have formatted the complete transcript of the three day conference for easy of navigation to provide you with the best possible Vioxx information. To contact a Vioxx Lawyer, click here for a FREE case evaluation.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH JOINT MEETING OF THE
ARTHRITIS ADVISORY COMMITTEE AND THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY
COMMITTEE
VOLUME I
Wednesday, February 16, 2005, 8:00 a.m
Hilton
Gaithersburg
620 Perry Parkway
Gaithersburg, Maryland
PARTICIPANTS:
Alastair J.J. Wood, M.D.,
Chair
Arthritis Advisory Committee:
Allan Gibofsky, M.D., J.D.Joan M. Bathon, M.D.
Dennis W. Boulware, M.D.
John J. Cush, M.D.
Gary Stuart Hoffman, M.D.
Norman T. Ilowite, M.D.
Susan M. Manzi, M.D., M.P.H.
Drug Safety and Risk Management Advisory Committee:
Peter A. Gross, M.D.
Stephanie Y. Crawford, Ph.D., M.P.H.
Ruth S.
Day, Ph.D.
Curt D. Furberg, M.D., Ph.D.
Jacqueline S. Gardner, Ph.D.,
M.P.H.
Eric S. Holmboe, M.D.
Arthur A. Levin, M.P.H., Consumer
Representative
Louis A. Morris, Ph.D.
Richard Platt, M.D., M.Sc.
Robyn S. Shapiro, J.D.
Annette Stemhagen, Dr.PH. Industry Representative
FDA Consultants (Voting):
Steven Abramson, M.D.
Ralph B. D'Agostino, Ph.D.
Robert H. Dworkin,
Ph.D.
Janet Elashoff, Ph.D.
John T. Farrar, M.D.
Leona M. Malone,
L.C.S.W., Patient Representative
Thomas Fleming, Ph.D.
Charles H.
Hennekens, M.D.
Steven Nissen, M.D.
Emil Paganini, M.D., FACP, FRCP
Steven L. Shafer, M.D.
Alastair J.J. Wood, M.D., Chair
National Institutes of Health Participants (Voting):
Richard O. Cannon, III, M.D.Michael J. Domanski, M.D.
Lawrence Friedman, M.D.
FDA Consultants (Non-Voting):
Byron Cryer, M.D. (Speaker and Discussant)Milton Packer, M.D. (Speaker only)
Guest Speakers (Non-Voting):
Garret A. FitzGerald, M.D.Ernest Hawk, M.D., M.P.H.
Bernard Levin, M.D.
Constantine Lyketsos, M.D., M.H.S.
FDA Participants:
Jonca Bull, M.D.David Graham, M.D., M.P.H.
Brian Harvey, M.D.
Sharon Hertz, M.D.
John Jenkins, M.D., F.C.C.P.
Sandy Kweder, M.D.
Robert O'Neill, Ph.D.
Joel Schiffenbauer, M.D.
Paul Seligman, M.D.
Robert Temple, M.D.
Anne Trontell, M.D., M.P.H.
Lourdes Villalba, M.D.
James Witter, M.D., Ph.D.
Steven Galson, M.D.
Kimberly Littleton Topper, M.S., Executive Secretary
|
If you or a loved one has been injured by a cox-2 specific inhibitor such as Bextra, Celebrex or Vioxx, please fill out our FREE case evaluation form. A Client Relations Representative will contact you shortly to discuss your potential case. Feel free as well to call us at (800) 476-6070 or email us at clientrelations@weitzlux.com
Weitz & Luxenberg is no longer accepting Vioxx
cases.
see also:
Sponsor: Vioxx
Vioxx Side Effects - Vioxx Lawyer - FDA Transcript - Sponsor: Vioxx (Rofecoxib)Your Vioxx side effects lawyer provides the complete transcript of the FDA meeting.
Q & A
Your Vioxx Lawyer - Vioxx, Celebrex & Bextra FDA Transcript - Q&AYour Vioxx lawyer provides the complete transcript of the FDA meeting.
FDA Transcript - Day 1
Conference for Safety - Vioxx, Celebrex & Bextra FDA Transcript Read here for the complete transcript of the FDA meeting for Vioxx
